VitaLonga Daily Brief — November 4, 2026
Wednesday, November 4, 2026 · 18 minutes
Valeria and Vitalis on avocado and mango for blood vessel function, an earlier bedtime in a prediabetes trial, blood fats tied to ultra-processed food, an earlier loss of new T cells in male mice, fear blurring danger and safety in the brain, night to night swings in sleep timing, dopamine that stays high after too much training, an experimental drug that reopened aging liver filters in rats, inflammation in pregnancy and autism-like traits in male mice, and caffeine and stimulant supplement reports. Educational only.
Stories from this day
- In 1,917 Mexican adults ages 50 and older, a weaker handgrip lined up with a higher chance of dying, and the link was stronger in men · GeroScience
- In 104 people with a sudden retinal-artery blockage, papaverine use lined up with better functional vision in a retrospective comparison · Frontiers in Aging
- A commentary says telomere RNA loops can stall DNA copying and, in some tumors, get used to keep chromosome ends going · Frontiers in Aging
- A Cell Metabolism letter questions whether a fasting GLP-1 level shows how many gut L-cells a person has · Cell Metabolism
- In aged rats, two weeks of the experimental drug cinaciguat cut circulating amyloid-beta about in half and brought LDL down to youthful levels · ScienceDaily
- In mice, the experimental drug KCL-286 reduced DNA breaks and brain inflammation in an Alzheimer's model · ScienceDaily
- In 13,423 adults ages 65 and older, higher balance, strength, and march scores lined up with a lower chance of dying over seven years · Harvard Health
- Eight weeks of a daily avocado and a cup of mango lined up with better blood-vessel function in 82 adults with prediabetes · ScienceDaily
- In pregnant mice, immune activation at day 12.5 lined up with placental injury and autism-like traits in male fetuses only · ScienceDaily
- In mice, fear made hippocampal maps of a safe place and a dangerous place overlap · ScienceDaily
- In middle-aged male mice, an earlier loss of new tumor-fighting immune cells lined up with weaker melanoma control · Lifespan.io
VitaLonga is an educational longevity resource, not a pharmacy, clinic, or doctor. Content is not medical advice and is not intended to diagnose, treat, cure, or prevent any disease (DSHEA). Supplements can interact with medications and are not appropriate in every pregnancy or health condition. Consult a licensed clinician, especially if you take medications, are pregnant or nursing, or have a diagnosed condition.